Neurocognitive Disorder Due to Alzheimer’s Disease
Neurocognitive disorder due to Alzheimer’s disease is the most common type of major neurocognitive disorder (NCD), accounting for up to 80% of all dementia cases. It is a progressive brain disease that gradually deteriorates memory, thinking, behavior, and the ability to carry out everyday activities.
Alzheimer’s disease is particularly prevalent in older adults, though it can also occur earlier in life as early-onset Alzheimer’s. As it advances, it deeply affects individuals and their families, making awareness and early intervention essential.
What Is Alzheimer’s-Related Neurocognitive Disorder?
In the DSM-5, Alzheimer’s falls under the category of Major Neurocognitive Disorder due to Alzheimer’s Disease. It is characterized by a gradual onset and ongoing cognitive decline, particularly in memory and learning, without periods of improvement.
This neurodegenerative disorder results from the build-up of beta-amyloid plaques and neurofibrillary tangles in the brain, which interfere with neuron function and lead to cell death, especially in areas responsible for memory and reasoning.
Signs and Symptoms
The symptoms of Alzheimer’s-related neurocognitive disorder appear slowly and worsen over time. Key features include:
- Memory impairment (especially short-term memory)
- Difficulty with problem-solving and decision-making
- Disorientation to time and place
- Language problems (forgetting words, repeating phrases)
- Mood and behavior changes (irritability, depression, anxiety)
- Trouble completing familiar tasks
- Social withdrawal
- Loss of initiative and poor judgment
In later stages, individuals may lose the ability to speak, walk, or recognize loved ones.
Stages of Alzheimer’s Disease
Alzheimer’s progresses through several stages:
- Preclinical Stage: No noticeable symptoms, but changes in the brain begin years before.
- Mild Stage (Early): Memory lapses and difficulties with planning, familiar tasks, or language.
- Moderate Stage (Middle): Increased confusion, trouble recognizing people, mood swings, and sleep disturbances.
- Severe Stage (Late): Significant loss of mental and physical function, including speech, mobility, and independence.
Diagnosis
Diagnosing Alzheimer’s-related NCD involves a combination of:
- Clinical history and mental status exams
- Cognitive testing (e.g., MMSE or MoCA)
- Brain imaging (MRI or CT scans to identify atrophy)
- Blood tests to rule out other causes (e.g., thyroid dysfunction, vitamin deficiency)
- Functional assessments to determine the impact on daily life
There is no single test to confirm Alzheimer’s, but advances in biomarkers and PET imaging are improving diagnostic accuracy.
Risk Factors
Several risk factors increase the likelihood of developing Alzheimer’s disease:
- Age (risk increases after age 65)
- Family history and genetics (e.g., APOE-e4 gene)
- Head trauma
- Poor cardiovascular health
- Sedentary lifestyle
- Low education or limited mental stimulation
- Chronic conditions like hypertension, diabetes, and obesity
Treatment and Management
While there is no cure, treatment focuses on slowing progression and improving quality of life:
1. Medications
- Cholinesterase inhibitors (e.g., donepezil, rivastigmine) for mild to moderate symptoms
- Memantine (NMDA receptor antagonist) for moderate to severe symptoms
- Antidepressants or antipsychotics (used cautiously to treat mood or behavioral symptoms)
2. Non-Pharmacological Interventions
- Cognitive stimulation therapy
- Routine and structure to reduce confusion
- Environmental modifications to ensure safety
- Supportive communication techniques for caregivers
3. Lifestyle Changes
- Regular exercise
- Heart-healthy diet (like the Mediterranean or DASH diets)
- Social engagement and mental activities
- Quality sleep and stress management
Caregiver Support
Caring for someone with Alzheimer’s is emotionally and physically demanding. Support includes:
- Respite care services
- Support groups and counseling
- Educational resources
- Assistance with legal and financial planning
Family and caregiver well-being is vital to maintaining long-term care.
Conclusion
Neurocognitive disorder due to Alzheimer’s disease is a deeply impactful condition that touches all areas of life. Although progressive and currently incurable, early diagnosis, evidence-based treatments, and strong support systems can enhance the quality of life for those living with Alzheimer’s and their loved ones. As research advances, the hope for more effective treatments continues to grow.